[Cost-effective drug utilization--what can the national drug agency do?].
Wesenberg
G R
GR
Madsen
S
S
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D011307:Drug Prescriptions / Q000191:economics*; D004363:Drug Utilization / Q000191:economics*; D006077:Government Agencies; D006801:Humans; D009664:Norway